Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for O05519

Entry ID Method Resolution Chain Position Source
AF-O05519-F1 Predicted AlphaFoldDB

No variants for O05519

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for O05519

No associated diseases with O05519

8 regional properties for O05519

Type Name Position InterPro Accession
domain ABC transporter-like, ATP-binding domain 4 - 259 IPR003439-1
domain ABC transporter-like, ATP-binding domain 327 - 541 IPR003439-2
domain AAA+ ATPase domain 28 - 245 IPR003593-1
domain AAA+ ATPase domain 352 - 525 IPR003593-2
conserved_site ABC transporter-like, conserved site 163 - 177 IPR017871-1
conserved_site ABC transporter-like, conserved site 445 - 459 IPR017871-2
domain ABC transporter Uup, C-terminal 562 - 638 IPR032524
domain ABC-transporter extension domain 231 - 316 IPR032781

Functions

Description
EC Number
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

2 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
DNA binding Any molecular function by which a gene product interacts selectively and non-covalently with DNA (deoxyribonucleic acid).

No GO annotations of biological process

Name Definition
No GO annotations for biological process

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MMILQVNQLS KSFGADTILN NIKLEVRNRD RIAIVGRNGA GKSTLLKIIA GQLSYEKGEI
70 80 90 100 110 120
IKPKDITMGY LAQHTGLDSK LTIKEELLTV FDHLKAMEKE MRAMEEKMAA ADPGELESIM
130 140 150 160 170 180
KTYDRLQQEF KDKGGYQYEA DVRSVLHGLG FSHFDDSTQV QSLSGGQKTR LALGKLLLTQ
190 200 210 220 230 240
PDLLILDEPT NHLDIDTLTW LEHYLQGYSG AILIVSHDRY FLDKVVNQVY EVSRAESKKY
250 260 270 280 290 300
HGNYSAYLDQ KAAQYEKDLK MYEKQQDEIA KLQDFVDRNL ARASTTKRAQ SRRKQLERMD
310 320 330 340 350 360
VMSKPLGDEK SANFHFDITK QSGNEVLRVQ DLTISYENQP PLLTEVSFML TRGESAALVG
370 380 390 400 410 420
PNGIGKSTLL KTLIDTLKPD QGTISYGSNV SVGYYDQEQA ELTSSKRVLD ELWDEYPGLP
430 440 450 460 470 480
EKEIRTCLGN FLFSGDDVLK PVHSLSGGEK ARLALAKLML QKANFLILDE PTNHLDLDSK
490 500 510 520 530 540
EVLENALIDY PGTLLFVSHD RYFINRIATR VLELSSSHIE EYLGDYDYYT EKKTEQLELE
550 560 570 580 590 600
KMNQQEETDK TPATVKSDSK RSYEEEKEWK KKERQRLRRI EEIETTVQTI EENISRNDEL
610 620 630 640
LCDPEVYQDH EKVQAIHADN EKLNQELESL LSEWEELSTE ED